secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAGENICS INC (OGEN)
CIK:        0001174940
Form:       8-K
Filed at:   2024-10-15T23:59:59+00:00
Accession:  0001493152-24-040974
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oragenics enters $10M ATM stock offering agreement with Dawson James
--------------------------------------------------------------------

- May sell up to $10M common shares at-the-market through Dawson James Securities.
- Sales agent commission of 3.0% of gross proceeds; reimbursement up to $30,000.
- Net proceeds to fund ONP-002 development and general corporate purposes.
- Shares sold on NYSE American; no obligation to sell any shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1174940/000149315224040974/0001493152-24-040974-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1174940/000149315224040974/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-040974

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer